Board of Directors at Akiri switch

Douglass Given, MD, PhD 
Doug given is one of the experienced people who is serving as the board at Akiri. He is also a Managing Partner at Health2047. He has provided his services as Chief Executive from start to January 2018 at Health2047 Inc. before joining health2047 and Akiri, he was serving life sciences investor Bay City Doug as an Investment Partner and General Partner. He is a physician and medical scientist by background.  He has also served as a global corporate and operating executive at Lilly, Monsanto, Schering Plough, and Mallinckrodt and a serial entrepreneur. He has also led three public biotechnology and biopharmaceutical companies as CEO.
He is a Director at Health2047 Inc., board Chair at Akiri Inc. and Arrowhead Pharmaceuticals Inc., Managing Partner at G5 Partners LLC, and serves on the board at First Mile Care Inc. and Vivaldi Biosciences Inc. He is also serving the advisory boards at the University of Chicago Medicine, Johns Hopkins Bloomberg School of Public Health, Stanford Medicine, Stanford Institute for Economic Policy Research (SIEPR), and The Houston Methodist Research Institute.
Dr. James Madara 
Dr. James Madara is serving as the CEO of the American Medical Association (AMA). He is providing his services as a Director at Akiri. He is serving Akiri with the valuable experience he’s gained while addressing strategic, operational and financial challenges at both medical and biosciences organizations.
James is passionate about creating a healthcare system that delivers better outcomes for all. Before joining AMA, he has served the University of Chicago, as CEO of the medical center and dean of the Biological Sciences Division and Pritzker School of Medicine. He has also worked as Timmie Professor and chair of the department of pathology and laboratory medicine at Emory University, and professor of pathology at Harvard Medical School. 
Ray Bingham, PhD 
Ray has more 35 years of working experience with businesses in high tech, chemical engineering, and hospitality real estate development. He is the Co-Founder and Founding Partner of Canyon Bridge Capital Partners, Inc. before joining, health2047 he served as a Strategic Advisor of EPIC Ventures, where he led investment activities in the Communications and Electronics sector. He has also served as a director at including Oracle, Cypress Semiconductor, Freescale Semiconductor, and Onyx Software.
The article contains the details of the board of directors at Akiri switch. Akiri is the first spun out the business of health2047 that is dealing with data liquidity.